Literature DB >> 1748470

Carrier-induced suppression of the antibody response to a 'self' hapten.

S Sad1, H M Gupta, G P Talwar, R Raghupathy.   

Abstract

Immunization of male rats and monkeys with gonadotropin-releasing hormone (GnRH) conjugated to a carrier results in a dramatic atrophy of the prostate. GnRH, linked to either diphtheria toxoid or tetanus toxoid as carrier, is now being evaluated for its use in the immunotherapy of hormone-dependent prostate enlargement in men. This report deals with the phenomenon of carrier-induced, epitope-specific regulation in the GnRH-carrier system. In experiments designed to assess the influence of the carrier on antibody responses to the 'self' hapten GnRH, we show that preimmunization with carriers diphtheria toxoid and tetanus toxoid results in a strain-dependent inhibition of anti-GnRH responses in mice. Results of adoptive transfer experiments indicate that T cells from carrier-presensitized mice are responsible for suppression of anti-haptenic antibodies and that T cells from conjugate-immunized mice, on the other hand, can actually help overcome hyporesponsiveness.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748470      PMCID: PMC1384596     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.

Authors:  L D Lise; D Mazier; M Jolivet; F Audibert; L Chedid; D Schlesinger
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

2.  Carrier-induced epitopic suppression is initiated through clonal dominance.

Authors:  M P Schutze; E Deriaud; G Przewlocki; C LeClerc
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

3.  Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies.

Authors:  S Avrameas
Journal:  Immunochemistry       Date:  1969-01

4.  Histopathological changes in reproductive organs of male Wistar rats following active immunization against LHRH.

Authors:  D K Giri; M K Chaudhuri; R Jayashankar; G S Neelaram; S Jayaraman; G P Talwar
Journal:  Exp Mol Pathol       Date:  1990-02       Impact factor: 3.362

5.  Influence of the genetic background and carrier protein on the antibody response to GnRH.

Authors:  S Sad; G P Talwar; R Raghupathy
Journal:  J Reprod Immunol       Date:  1991-02       Impact factor: 4.054

6.  Use of prior vaccinations for the development of new vaccines.

Authors:  H M Etlinger; D Gillessen; H W Lahm; H Matile; H J Schönfeld; A Trzeciak
Journal:  Science       Date:  1990-07-27       Impact factor: 47.728

7.  Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum.

Authors:  H M Etlinger; A M Felix; D Gillessen; E P Heimer; M Just; J R Pink; F Sinigaglia; D Stürchler; B Takacs; A Trzeciak
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

8.  Carrier-induced epitopic suppression, a major issue for future synthetic vaccines.

Authors:  M P Schutze; C Leclerc; M Jolivet; F Audibert; L Chedid
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

9.  Semisynthetic anti-LHRH vaccine causing atrophy of the prostate.

Authors:  R Jayashankar; M K Chaudhuri; O Singh; A Alam; G P Talwar
Journal:  Prostate       Date:  1989       Impact factor: 4.104

10.  Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memory.

Authors:  L A Herzenberg; T Tokuhisa; D R Parks; L A Herzenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  8 in total

1.  Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.

Authors:  Qian Qin; Zhaojun Yin; Philip Bentley; Xuefei Huang
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

2.  Carrier properties of a protein derived from outer membrane protein A of Klebsiella pneumoniae.

Authors:  I Rauly; L Goetsch; J F Haeuw; C Tardieux; T Baussant; J Y Bonnefoy; N Corvaia
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae.

Authors:  L Goetsch; A Gonzalez; H Plotnicky-Gilquin; J F Haeuw; J P Aubry; A Beck; J Y Bonnefoy; N Corvaïa
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.

Authors:  Suttipun Sungsuwan; Zhaojun Yin; Xuefei Huang
Journal:  ACS Appl Mater Interfaces       Date:  2015-08-03       Impact factor: 9.229

5.  Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man.

Authors:  M R Downham; T R Auton; A Rosul; H L Sharp; L Sjöström; A Rushton; J P Richards; T G K Mant; S M Gardiner; T Bennett; J F Glover
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

6.  Bypass of carrier-induced epitope-specific suppression using a T-helper epitope.

Authors:  S Sad; K Rao; R Arora; G P Talwar; R Raghupathy
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

7.  Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier.

Authors:  J A Chabalgoity; B Villareal-Ramos; C M Khan; S N Chatfield; R D de Hormaeche; C E Hormaeche
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

8.  Efficacy and Safety of the Immunization with DNA for Alzheimer's Disease in Animal Models: A Systematic Review from Literature.

Authors:  Yandara Akamine Martins; Cristiane Jumko Tsuchida; Patrícia Antoniassi; Izabel Galhardo Demarchi
Journal:  J Alzheimers Dis Rep       Date:  2017-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.